一种可预防白喉-破伤风类毒素和无细胞吸附百日咳-乙肝(重组)-脊髓灰质炎的联合疫苗(DtaP-HepB-IPV,商品名为 PEDIARIX)获得美国食品药品管理局(FDA)批准用于2、4、6个月龄的婴儿免疫接种。联合疫苗中的所有成分均是美国免疫实施咨询委员会(ACIP)、美国儿科学会传染病委员会和美国家庭内科医师学会推荐常规使用 A combination vaccine (DtaP-HepB-IPV under the trade name PEDIARIX) that prevents diphtheria-tetanus toxoid and cell-free pertussis-hepatitis B (recombinant) -polio was approved by the U.S. Food and Drug Administration Infants in 2, 4 and 6 months of age are immunized. All of the ingredients in the combination vaccine are recommended by the American Advisory Committee on Immunization Practice (ACIP), the American Academy of Pediatrics Infectious Diseases Commission and the American Academy of Family Physicians